New pill helps control blood sugar in type 2 diabetes patients
NCT ID NCT04878393
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 32 times
Summary
This study followed 650 adults with type 2 diabetes in Japan who were prescribed oral semaglutide (Rybelsus®) by their doctors. The goal was to see how well the once-daily pill lowers blood sugar and to track any side effects over 8-10 months. Participants completed a questionnaire about how they took their medication during regular clinic visits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Master Centre for Japan
Tokyo, 1000005, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.